Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications.

Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications. Abstract Text:

Julie L Hudson,G Edward Miller,James B Kirby,Julie L Hudson,G Edward Miller,James B Kirby,

OBJECTIVES: To document and explain racial/ethnic differences in the use of stimulant drugs among US children. DATA AND METHODS: We use a nationally representative sample of children ages 5-17 years old from the Medical Expenditure Panel Survey (MEPS) for the years 2000-2002. We estimate race-specific means and regressions to highlight differences across groups in individual/family characteristics that may affect stimulant use and differences in responses to these characteristics. Then, we use Oaxaca-Blinder decomposition methods to quantify the portion of differential use explained by differences in individual/family characteristics. Finally, we use pooled regressions with race/ethnicity interactions to formally test the hypothesis that responses to perceived mental health and behavioral problems vary across groups. RESULTS: White children are about twice as likely to use stimulants as either Hispanic or Black children. Differences in individual/family characteristics account for about 25% of the difference between whites and Hispanics, but for none of the difference between whites and blacks. Pooled regressions show that racial/ethnic gaps in stimulant use persist among children with otherwise similar reported mental health conditions. CONCLUSIONS: Our finding that the majority of racial/ethnic differences in children's stimulant use is explained by differences in responses to individual/family characteristics highlights the importance of further research to examine the reasons for these differences. It is striking that children with otherwise similar reports of mental health problems have such different outcomes in terms of stimulant use. Potential explanations range from discrimination to cultural differences by race/ethnicity or community.

Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications. Publishing Authors By Initials

JL Hudson,GE Miller,JB Kirby,JL Hudson,GE Miller,JB Kirby,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Medical care

VOLUME: 45

Page Numbers: 1068-75

Journal Abbreviation:

ISSN: 0025-7079

DAY: 30

MONTH: Nov

YEAR: 2007

Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 230027

Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications.

AFFILIATION: Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality/NIH, 540 Gaither Road, Rockville, MD 20850, USA. jhudson@ahrq.gov

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Med Care

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications Related Publications

• A HISTOCHEMICAL AND ELECTRON MICROSCOPICAL STUDY OF THE FIBRINOID OF THE MOUSE PLACENTA.
• A journey through your prostate.
• Amino acids constituents of tissues and isolated chromosomes of Drosophila.
• Antibodies to stem cell marker antigens reduce engraftment of hematopoietic stem cells.
• Biochemical individuality; variation in the urinary excretion of lysine, threonine, leucine, and arginine.
• Chemosensory pathways, motility and development in Myxococcus xanthus.
• Comparative genomics of Streptomyces avermitilis, Streptomyces cattleya, Streptomyces maritimus and Kitasatospora aureofaciens using a Streptomyces coelicolor microarray system.
• Continuous-flow particle separation by 3D Insulative dielectrophoresis using coherently shaped, dc-biased, ac electric fields.
• Dose-volume characteristics of a 50-kV electronic brachytherapy source for intracavitary accelerated partial breast irradiation.
• Epidemiology of bladder and cloacal exstrophies in New york state, 1983-1999.
• Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications.
• Extraction of cataract in presence of fluid vitreous.
• Further experiments in mice with p-diazoaminobenzene.
• Heart field: from mesoderm to heart tube.
• Is obesity a risk factor for prostate cancer?
• Isolation and characterization of two protease inhibitors from bovine plasma.
• Lifestyle and the urologist.
• Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations.
• Proteomic analysis of ovomucoid hypersensitivity in mice by two-dimensional difference gel electrophoresis (2D-DIGE).
• Rapid identification of Staphylococcus aureus in blood cultures by use of the direct tube coagulase test.
• Report from london.
• The action of 2-aminofluorene in three pure strains of mice.
• The clinical use of a prosthesis to prevent overdistention of the remaining lung following pneumonectomy.
• The rupture of the zonule in intracapsular cataract extraction; a new method.
• The rural rotation in a medical technology program: a ten-year retrospective study.
• Use of hyaluronidase with local anesthetic agents in dentistry.
• Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: An alternative to traditional mortality assessment using underlying cause of death statistics.
• Ventricular escape in acute rheumatism.
• Vital statistics: a poor source of data for investigating the association between paternal age and birth defects.
• multicellular development in Myxococcus xanthus is stimulated by predator-prey interactions.